Hi @Laurie @TealSister @CurlyHair @Flowergirl
Here is the latest information about funding for Lynparza. Each of the provinces are now deciding whether or not to cover the cost of Lynparza. Some may say yes, others may say no.
Until these decisions are made, the process for patients wanting to access Lynparza remains:
Please discuss this with your doctor and make sure you are enrolled in the AstraZeneca's Patient Support Program.
Treatment news: Quebec and Yukon have approved public funding of Lynparza for certain cases of recurrent BRCA-mutated #ovariancancer. Remaining provinces and territories are continuing deliberations and we are hopeful that this treatment will soon be available across the country.
"Health Canada has approved this drug only for the "maintenance treatment of adult patients with platinum-sensitiverelapsed (PSR) BRCA-mutated (germline or somatic) high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete response or partial response) to platinum-based chemotherapy.(Platinum-sensitive relapse is defined as disease progression occurring at least 6 months following completion of platinum chemotherapy.)"
As far as I know, this means that Lynparza is not an option if the cancer is platinum resistant or non BRCA status.
Has your doctor suggested that you should take Lynparza?
#BritishColumbia and #Alberta now fund #Lynparza for women in recurrence with platinum-sensitive BRCA-mutated high-grade serous epithelial #ovariancancer. These provinces join Quebec, Ontario, Yukon and the Non-Insured Health Benefits Program in offering public funding for this approved treatment.
It looks like you might be new to OVdialogue. Please register or sign in to participate in discussions.